John Stone
Impact in
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
- Oncology top 5%
- PARP inhibition in cancer therapy
Papers in
- Oncology 4
- CAR-T cell therapy research 2
- PARP inhibition in cancer therapy 1
-
- Cancer-related gene regulation 1
- Signaling Pathways in Disease 1
- Protein Degradation and Inhibitors 1
- Co-authors
- Jan Lubiński (1 shared paper)Timothy A. Yap (1 shared paper)Jacques De Grève (1 shared paper)Stan B. Kaye (1 shared paper)Jan H.M. Schellens (1 shared paper)Roger A’Hern (1 shared paper)Andrew Tutt (1 shared paper)David S. Boss (1 shared paper)
- Partner nations
- United KingdomUnited StatesJapan
In The Last Decade
John Stone
5 papers receiving 767 citations
John Stone's Hit Papers
Peers
Comparison fields: 5 of 48
- Reproductive Medicine 280
- Oncology 628
- Genetics 217
- Cancer Research 110
- Molecular Biology 427
Countries citing papers authored by John Stone
This map shows the geographic impact of John Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Stone more than expected).
Fields of papers citing papers by John Stone
This network shows the impact of papers produced by John Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Stone. The network helps show where John Stone may publish in the future.
Co-authors
The 25 scholars most cited alongside John Stone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval Hit paper breakdown → | 2010 | 745 |
| 2 | 2024 | 27 | |
| 3 | 2021 | 5 | |
| 4 | 2024 | 2 | |
| 5 | 2022 | 1 |
About John Stone
John Stone is a scholar working on Oncology, Molecular Biology, Immunology, Hematology and Genetics, having authored 5 papers that have together received 780 indexed citations. Recurring topics across this work include CAR-T cell therapy research (2 papers), Cancer-related gene regulation (1 paper), Signaling Pathways in Disease (1 paper), BRCA gene mutations in cancer (1 paper), PARP inhibition in cancer therapy (1 paper), Biosimilars and Bioanalytical Methods (1 paper), Protein Degradation and Inhibitors (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Reproductive Medicine (280 citations), Oncology (628 citations), Genetics (217 citations), Cancer Research (110 citations) and Molecular Biology (427 citations). John Stone has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Jan Lubiński, Timothy A. Yap, Jacques De Grève, Stan B. Kaye, Jan H.M. Schellens, Roger A’Hern, Andrew Tutt, David S. Boss, Susan Shanley and Johann S. de Bono. Their work appears in journals such as Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.